Table 1 Clinical characteristics of control and RA patients including the two RA subgroups.
From: Plasma fibrinogen, d-dimer, and fibrin degradation product as biomarkers of rheumatoid arthritis
RA (N = 105) | Control (N = 102) | Low activity RA (N = 52) | Active RA (N = 53) | |
|---|---|---|---|---|
Age (years) | 55.26 ± 16.27 | 53.69 ± 14.95 | 53.28 ± 19.00 | 56.98 ± 13.64 |
Gender (F/M) | 78/27 | 76/26 | 39/13 | 39/14 |
BMI (kg/m2) | 25.2 ± 2.7 | 25.8 ± 3.2 | 25.5 ± 3.1 | 24.7 ± 2.3 |
CRP (mg/L) | 19.48 (7.21–50.62) | 1.9 (0.7–2.9) | 10.95 (5.87–16.9) | 30.30 (10.56–53.90) |
ESR (mm/h) | 43.0 (17–76) | 5.61 (2.93–10.45) | 28.0 (15–62) | 57.0 (21–83) |
RF (IU/mL) | 171.56 (25.2–410.00) | 5.02 (2.30–13.40) | 131.83 (21.20–310.00) | 275.29 (35.16–907.0) |
Anti-CCP (U/mL) | 273.6 (43.8–395.0) | 11.1 (6.2–17.5) | 251.3 (20.6–375.0) | 306.8 (91.7–400.0) |
WBC (109/L) | 6.65 ± 3.02 | 6.09 ± 2.23 | 6.42 ± 2.82 | 6.88 ± 3.36 |
RBC (1012/L) | 4.09 ± 0.64 | 4.64 ± 0.62 | 4.24 ± 0.51 | 3.93 ± 0.46 |
Hb (g/L) | 118.48 ± 20.77 | 137.20 ± 18.28 | 123.12 ± 20.38 | 110.37 ± 17.95 |
PLT (109/L) | 235.12 ± 82.71 | 202.63 ± 76.27 | 216.05 ± 84.98 | 248.87 ± 89.13 |
FIB (mg/dL) | 370.40 ± 126.02 | 274.73 ± 73.39 | 315.58 ± 96.44 | 401.76 ± 122.10 |
d-dimer (µg/L) | 2962.78 ± 1892.94 | 907.13 ± 545.65 | 2145.61 ± 975.12 | 4382.46 ± 1881.72 |
FDP (mg/L) | 19.43 ± 12. 31 | 2.15 ± 1.03 | 5.17 ± 3.48 | 37.13 ± 13.44 |
